Startups
Corden Pharma - A Full-Service CDMO
Edit

Corden Pharma - A Full-Service CDMO

Trusted
http://www.cordenpharma.com/
Last activity: 15.09.2026
Active
Categories: CommerceDevelopmentDrugLogisticsManufacturingProductProductionServiceSupplyTechnology
CordenPharma is your full-service partner in the Contract Development & Manufacturing (CDMO) of APIs, Drug Products and associated Packaging Services. Through a network of cGMP facilities across Europe and the US organized under four technology platforms – Peptides, Lipids & Carbohydrates – Injectables - Highly Potent & Oncology - Small Molecules - CordenPharma experts translate complex ideas, processes and projects at any stage of development into high-value products.

<< Peptides, Lipids & Carbohydrates >>

• Synthetic Peptide API Production
- Solid-phase, Liquid-phase, Hybrid Synthesis
- cGMP & non-cGMP
• Synthetic Lipids
• Carbohydrates

<< Sterile Injectables >>

• New Development & Commercial Suites for Aseptic Filling with > 60.000 units
per day (Pre-filled Syringes, Liquid or Lyophilized Vials)
• Packaging, Labeling & Logistics
• Sterile Emulsion Technology
• Large Pre-Filled Syringes
• Clinical Trial Services

<< Highly Potent & Oncology >>

• API Development & Commercial Manufacturing
(SafeBridge Category 4, OEL ≤1 ng/m3)
- New Development & Scale-up Capacity for Phase I/II Supply
• Drug Product Development & Manufacturing
- New Development Suite (CTD2) for Mid-scale Oral Dosage (up to 20 kg)
- Sterile Liquid & Lyophilization
- Primary & Secondary Packaging

<< Small Molecules >>

• Development & Commercial Manufacturing
- Intermediates
- APIs & Excipients
- Clinical Supply Phases I-III
• Proprietary & Generic Advanced Intermediates & APIs

Visit > www.cordenpharma.com
LinkedInYoutubeEmail
Followers
15.14K
Website visits
36.8K /mo.
Mentions
19

Overview

Location
Germany, Baden-Württemberg, Plankstadt
Employees
1001-5000
Founded date
2006

Mentions in press and media 19

DateTitleDescription
Sign up to seeSign up to seeSign up to see
Sep 10, 2026/C O R R E C T I O N -- CordenPharma/In the news release, CordenPharma Boosts Aseptic Fill-Finish Capacity to 500 Million Sterile Injectable Units Per Year, issued 10-Sep-2026 by CordenPharma over PR Newswire, we are advised by the company that changes have been made. The comp...
Aug 11, 2026Peptide Synthesis Market Trends: Drug Development and Biopharmaceutical Innovation Driving GrowthThe peptide synthesis market is witnessing strong growth as peptides gain increasing importance in pharmaceutical research, therapeutic development, diagnostics, and biotechnology. Peptide synthesis enables the production of customized pept...
May 27, 2026CordenPharma Acquires AmbioPharm to Expand Global Peptide API CapacityAcquisition strengthens U.S. peptide manufacturing capabilities and broadens global expertise in complex peptide APIs CordenPharma has entered into an agreement to acquire AmbioPharm, a U.S.-headquartered peptide CDMO with facilities in Nor...
Mar 25, 2026VitriVax leases space in Boulder’s Flatiron ParkGetting your Trinity Audio player ready... Fresh on the heels of signing a major lease with Corden Pharma, BioMed Realty LLC has landed another biotech tenant just across the street. Already have an account Log In This article is only avail...
Feb 25, 2026Boulder County students share science knowledge at regional fairGetting your Trinity Audio player ready... Nederland Middle/Senior High junior Amika Begin turned her interest in sports marketing into a science project, investigating if social media engagement is an important factor in getting the deals ...
Dec 22, 2025Кибербезопасность на грани сингулярности: шансы на выживание в ИИ-войнеИскусственный интеллект находит все более широкое применения для автоматизации и оптимизации кибератак. Средства ИИ позволяют злоумышленникам генерировать вредоносный код, анализировать системы и обходить системы защиты, по минимуму привлек...
Oct 28, 2025Top 7 Managed Detection and Response (MDR) Providers You Should Know in 2025Share Share Share Share Email In today’s shifting cybersecurity climate, it is clear Managed Detection and Reponse (MDR) services are indispensable for organizations to uncover and respond to threats effectively and efficiently. Here we are...
Jul 22, 2025Corden Pharma plans new manufacturing building at Boulder campusSwiss pharmaceutical manufacturer Corden Pharma International GmbH has submitted a proposal to Boulder city planning officials for a new manufacturing building on its Boulder campus, where the drug company is investing hundreds of millions ...
Mar 5, 2025CordenPharma Expands Peptide Platform with more than 500 Million Euro Greenfield Facility Construction in the Basel Region of SwitzerlandCordenPharma is making a record investment of >€1 billion over the next 3 years in building and / or expanding small, medium, and large peptide manufacturing facilities across Europe and the US. In Switzerland, CordenPharma will invest &...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In

FAQ about Corden Pharma - A Full-Service CDMO

When was Corden Pharma - A Full-Service CDMO founded?

Corden Pharma - A Full-Service CDMO was founded in 2006.

What has the press written about Corden Pharma - A Full-Service CDMO?

Parsers VC has collected 19 articles mentioning Corden Pharma - A Full-Service CDMO, among them “/C O R R E C T I O N -- CordenPharma/” (Sep 10, 2026) and “Peptide Synthesis Market Trends: Drug Development and Biopharmaceutical Innovation Driving Growth” (Aug 11, 2026).

Is Corden Pharma - A Full-Service CDMO still active?

Yes, Corden Pharma - A Full-Service CDMO is active; its latest activity on Parsers VC dates from Sep 15, 2026.